Skip to Content

Cronos Group Inc

CRON: XTSE (CAN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CAD 2.40NmyHvzchflq

Cronos' Earnings: Respectable Progress on Narrowing Losses but Positive EBITDA Remains Years Away

Cronos’ full-year 2022 net revenue after excise taxes and adjusted EBITDA loss of $92 million and $81 million, respectively, weren’t far from our forecast revenue of $93 million and adjusted EBITDA loss of 77 million. With few surprises during the quarter, we’ve largely maintained our long-term forecasts and hold our fair value estimates of $4 and CAD 5.50 for no-moat Cronos. The stock looks undervalued in 4-star territory, but we see 5-star opportunities elsewhere among American multistate operators and Canadian licensed producers.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CRON so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center